Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD44 | P16070 | 1/20 | 0.45 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
| ▸ | MPL | P40238 | 1/20 | 0.30 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5958756 | 0.86 | CD44 (0.46) | CD44GABRA1GABRB2KIF11CYP3A4 | |
| SCHEMBL77056 | 0.81 | CD44 (0.50) | CD44GABRA1GABRB2KIF11CYP3A4 | |
| SCHEMBL29512913 | 0.81 | CD44 (0.50) | CD44GABRA1GABRB2KIF11CYP3A4 | |
| SCHEMBL5958686 | 0.81 | CD44 (0.42) | CD44GABRA1GABRB2KIF11CYP3A4 | |
| SCHEMBL5958716 | 0.79 | CD44 (0.41) | CD44GABRA1GABRB2KIF11 | |
| SCHEMBL23591999 | 0.79 | CD44 (0.48) | CD44GABRA1GABRB2KIF11CYP3A4 | |
| SCHEMBL5958679 | 0.78 | CD44 (0.46) | CD44GABRA1GABRB2KIF11CYP3A4 | |
| SCHEMBL30154643 | 0.74 | GABRA1 (0.56) | CD44GABRA1GABRB2KIF11CYP3A4 | |
| SCHEMBL1804107 | 0.74 | GABRA1 (0.56) | CD44GABRA1GABRB2KIF11CYP3A4 | |
| SCHEMBL8223624 | 0.72 | CD44 (0.50) | CD44GABRA1GABRB2KIF11CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1418171-B1 | Verfahren zur Herstellung von Perfluoroalkylanilins | SALTIGO GMBH (DE) | 2011-12-14 | — | — | EP | disclosed |
| US-7041852-B2 | Perfluoroalkylanilines | BAYER CHEMICALS AG (DE) | 2006-05-09 | — | — | US | disclosed |
| US-20040152898-A1 | Perfluoroalkylanilines | LANXESS DEUTSCHLAND GMBH (DE) | 2004-08-05 | — | — | US | disclosed |
| EP-1418171-A1 | Perfluoroalkylanilins | Bayer Chemicals AG (DE) | 2004-05-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040152898-A1 | Perfluoroalkylanilines | PFAS, AFF2, AFF4 | CD44 4589/4885GABRA1 1868/4885GABRB2 2287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.